FDA-AACR Workshop Examines the Practice and Promise of Real-world Evidence in Oncology
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
Category: Research
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
In the past couple of decades, progress against cancer has created a new generation of survivors. Today, more than...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
A pair of studies presented at the AACR Annual Meeting 2019 demonstrated encouraging clinical outcomes with two different chimeric...
There has been a rapid expansion of technology in recent years, from artificial intelligence to intensive genetic sequencing to...
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...